Drug companies to pay Hawaii USD 700 million to settle Plavix blood thinner lawsuit
(You can now subscribe to our
(You can now subscribe to our Economic Times WhatsApp channel
Pharmaceutical companies have agreed to pay Hawaii USD 700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general's office has announced. A court ruling last year ordered Bristol Myers Squibb Company and three U.S.-based subsidiaries of French pharmaceutical company Sanofi to pay a combined USD 916 million.But before an appeal was decided, a settlement was reached for the lower amount, the attorney general's office said.In a joint statement on Friday, the companies said they "are pleased to resolve this litigation, and to continue their companies' focus on discovering, developing, and delivering innovative medicines to patients.""Plavix has helped millions of people with cardiovascular disease around the world for nearly 30 years and it continues to be endorsed as a first-line therapy by leading treatment guidelines across the globe," the statement added.First Circuit Court Judge James Ashford found that there was a risk that about 30 per cent of patients, particularly non-Caucasians, might have a "diminished response" to Plavix but the companies did not update their labels, Attorney General Anne Lopez said last year.Neither company has admitted wrongdoing.Governor Josh Green called it a "landmark settlement" and a "major victory" for the state.The settlement divides the USD 700 million equally between Bristol Myers Squibb and Sanofi, with the funds to be paid by wire transfer by June 9, the attorney general's office said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
27 minutes ago
- Time of India
MCM to hire 376 sanitation workers for road sweeping
Gurgaon: The Haryana Urban Local Bodies (ULB) department has given administrative approval for sweeping work in all sector-dividing roads under the jurisdiction of MCM, IMT Sector 1 to 8, and villages falling within the civic body limits. The estimated cost of the project for five years is Rs 35.1 crore. As per the proposal, the civic body will now hire 376 sanitation workers for manual sweeping of all these roads, in addition to its existing fleet of five sweeping machines. "We have received approval for the manual sweeping of roads in the residential and market areas. Under this contract, we will get 376 sanitation staff for road sweeping. We already have 55 sanitation workers. It will take us at least a month to commence the work since the revised request for proposal guidelines are yet to be issued by the state govt," MCM commissioner Ayush Sinha told TOI. You Can Also Check: Gurgaon AQI | Weather in Gurgaon | Bank Holidays in Gurgaon | Public Holidays in Gurgaon | Gold Rates Today in Gurgaon | Silver Rates Today in Gurgaon However, the ULB department, in its approval, has directed MCM to give preference to mechanised sweeping over manual sweeping, in accordance with the latest directions. The directives mention that for roads having a width of 9 metres and above in NCR districts, and 12 metres and above in non-NCR districts, mechanised sweeping should be the first choice. The corporation should ensure optimum utilisation of existing infrastructure and safai karamcharis before floating the tender, a letter sent by the ULB department to MCM read, adding that funds released for the project should solely be utilised to increase the efficiency of the civic body and not for any other purpose. In June this year, MCM imposed a Rs 9.2 crore fine on a private firm for inadequate workforce and equipment between March and May 2025. The contractor's Rs 13.2 crore invoice for services, including manual road sweeping, bush removal, and drain cleaning, between Feb and May 2025, also came under scrutiny. The agency had a two-year contract with MCM that ended in Feb 2025. It was then given an extension of three months, until May 31, for their work. In April, a Rs 4.3 crore penalty was imposed on the company for delay in delivering work. The company blamed this on bribery among senior MCM officials and payment delays, leading to the transfer of the then MCM commissioner. A sanitation standing committee reviewed the work of the agency between Feb 20 and May 19, 2025. A meeting was held on June 4, in which the committee recommended deducting over Rs 9.2 crore from the agency's Rs 13.2 crore bill, approving payment of only around Rs 4 crore. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.
Time of India
an hour ago
- Time of India
CDSCO issues alert on Novo drugs after reported theft
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel New Delhi: The Central Drugs Standard Control Organization ( CDSCO ) has issued an alert to healthcare professionals to be careful in prescribing Novo Nordisk products after the company said some of its products, including weight-loss drug semaglutide and diabetes treatments insulin Aspart and Degludec, were central pharma regulator has also directed patients and consumers to be careful and procure their products from authorised sources only with due alert, issued Thursday, has also been sent to all state drug control offices with instructions of a strict vigil on the movement of the products in the market and initiate necessary action under the Drugs and Cosmetics Act, note says Novo Nordisk has informed about a theft of its products during transit from its Bhiwandi Hub to milk route (Nagpur, Raipur, Cuttack, and Kolkata).The products under consideration are rDNA origin injectables which are required to be stored at a certain temperature and quality of the products may be compromised if the products are not handled in proper storage conditions."The products under consideration are DNA origin injectables which are required to be stored at 2-8°C. The quality of the products may be compromised if the products are not handled in proper storage conditions since the formulations are supposed to be maintained at 2°C to 8°C failing which, would impact the quality of the product and in turn impact the safety of the patients," said the advisory by India's drug matter is currently under Police investigation, it email sent to Novo Nordisk did not elicit any response till the press time.
Time of India
2 hours ago
- Time of India
Over 20% of Russia's war-period crude exports bought by India: CREA
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel India purchased ₹132 billion (about ₹13.39 lakh crore) worth of Russian oil since the Ukraine war began in early 2022, accounting for a fifth of Moscow's ₹640 billion oil export earnings in the period, according to Finland-based Centre for Research on Energy and Clean Air (CREA).India's oil imports from Russia trail China's ₹193 billion but exceed those of the EU and Turkiye at ₹105 billion and ₹71 billion, respectively, CREA also bought ₹16 billion of Russian coal, taking its total fossil fuel imports from Moscow to ₹148 billion. Russia, in all, earned ₹931 billion from exports of oil, gas, and coal since the start of the with fossil fuel imports of ₹268 billion, has been Russia's largest buyer, ahead of the EU (₹213 billion), India (₹148 billion), and Turkiye at ₹111 also led in Russian coal purchases (₹39 billion), while EU topped gas imports (₹105 billion), followed by China (₹36 billion) and Turkiye (₹29 billion). India did not import gas from Russia during this governments have repeatedly accused India and China of bankrolling Moscow's war efforts through such purchases. But CREA's estimates show the EU itself contributed nearly a quarter of Russia's fossil fuel earnings since February compiles its data from multiple sources on Russian export volumes and prices, applying assumptions to arrive at estimates. It has also been pressing for tougher sanctions and stricter enforcement of oil price cap to reduce Moscow's Western rhetoric, no outright ban has been imposed on Russian oil, keeping it available on global markets and allowing India, China, and others to buy it at discounted rates. Recently, however, the US has stepped up criticism, with Treasury Secretary Scott Bessent accusing India and some of its wealthiest families of "unacceptable opportunistic arbitrage" by buying and reselling Russian oil and reaping $16 billion in excess profit. He did not provide details on how the $16 billion excess profit was has imposed a 25% penalty on Indian imports for purchasing Russian oil. India has called the penalty, which takes effect on August 27, unjustified and unreasonable. Indian refinery executives said they will continue buying Russian oil despite the threat of penalty.
